Varma Mutual Pension Insurance Co Has $12.87 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Varma Mutual Pension Insurance Co reduced its HCA stake by 8.9% in Q4 to 27,563 shares, worth about $12.87 million.
• Analyst sentiment is broadly positive (16 Buy, 7 Hold, 1 Sell) with an average rating of "Moderate Buy" and an average price target of $517.82, and several firms recently raised their targets.
• HCA reported quarterly EPS of $7.15 (missing estimates by $0.04) on $19.11B revenue and issued FY2026 guidance of 29.10–31.50 EPS (consensus ~30.05).

Varma Mutual Pension Insurance Co decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 8.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 27,563 shares of the company's stock after selling 2,700 shares during the quarter. Varma Mutual Pension Insurance Co's holdings in HCA Healthcare were worth $12,868,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Palisade Asset Management LLC acquired a new stake in HCA Healthcare during the 3rd quarter valued at $26,000. Holos Integrated Wealth LLC acquired a new stake in HCA Healthcare during the 4th quarter valued at $29,000. Ares Financial Consulting LLC bought a new position in HCA Healthcare during the 4th quarter worth $31,000. JPL Wealth Management LLC bought a new position in HCA Healthcare during the 3rd quarter worth $33,000. Finally, Aventura Private Wealth LLC bought a new position in HCA Healthcare during the 4th quarter worth $34,000. Institutional investors and hedge funds own 62.73% of the company's stock.

Analyst Ratings Changes

HCA has been the topic of several recent research reports. Weiss Ratings reiterated a "buy (b)" rating on shares of HCA Healthcare in a research report on Friday, March 27th. UBS Group increased their price objective on HCA Healthcare from $598.00 to $635.00 and gave the stock a "buy" rating in a research report on Monday, February 23rd. The Goldman Sachs Group increased their price objective on HCA Healthcare from $520.00 to $558.00 and gave the stock a "buy" rating in a research report on Wednesday, January 28th. Deutsche Bank Aktiengesellschaft decreased their price target on HCA Healthcare from $558.00 to $540.00 and set a "buy" rating on the stock in a research report on Tuesday, April 28th. Finally, Mizuho raised their price target on HCA Healthcare from $540.00 to $585.00 and gave the stock an "outperform" rating in a research report on Wednesday, February 25th. Sixteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $517.82.

HCA Healthcare Stock Performance

Shares of NYSE HCA opened at $427.71 on Tuesday. HCA Healthcare, Inc. has a 52 week low of $330.00 and a 52 week high of $556.52. The stock's fifty day moving average is $497.66 and its 200 day moving average is $486.41. The stock has a market capitalization of $94.88 billion, a P/E ratio of 14.71, a PEG ratio of 1.37 and a beta of 1.18.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, April 24th. The company reported $7.15 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.19 by ($0.04). HCA Healthcare had a net margin of 8.89% and a negative return on equity of 295.93%. The business had revenue of $19.11 billion during the quarter, compared to the consensus estimate of $19.09 billion. During the same quarter in the prior year, the firm earned $6.45 EPS. The business's revenue was up 4.3% on a year-over-year basis. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 30.05 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, June 30th. Shareholders of record on Tuesday, June 16th will be given a $0.78 dividend. This represents a $3.12 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date is Tuesday, June 16th. HCA Healthcare's payout ratio is currently 10.73%.

Insider Buying and Selling at HCA Healthcare

In other news, SVP Christopher F. Wyatt sold 4,000 shares of the business's stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $505.00, for a total transaction of $2,020,000.00. Following the sale, the senior vice president directly owned 44,379 shares in the company, valued at approximately $22,411,395. The trade was a 8.27% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, SVP Jennifer Berres sold 8,020 shares of the business's stock in a transaction dated Wednesday, February 11th. The stock was sold at an average price of $514.58, for a total value of $4,126,931.60. Following the sale, the senior vice president owned 11,993 shares in the company, valued at approximately $6,171,357.94. This trade represents a 40.07% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 13,714 shares of company stock worth $7,050,460 over the last 90 days. Insiders own 1.50% of the company's stock.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.